MENU
+Compare
BOUT
ETF ticker: NYSE ARCA
AS OF
Jan 14 closing price
Price
$38.42
Change
-$0.10 (-0.26%)
Net Assets
13.49M

BOUT stock forecast, quote, news & analysis

The investment seeks to track, before fees and expenses, the performance of the IBD® Breakout Stocks Index (the "index")... Show more

Category: #Mid-Cap Growth
BOUT
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for BOUT with price predictions
Jan 14, 2026

Momentum Indicator for BOUT turns positive, indicating new upward trend

BOUT saw its Momentum Indicator move above the 0 level on December 22, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 96 similar instances where the indicator turned positive. In of the 96 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for BOUT just turned positive on January 05, 2026. Looking at past instances where BOUT's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .

BOUT moved above its 50-day moving average on January 05, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for BOUT crossed bullishly above the 50-day moving average on January 05, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BOUT advanced for three days, in of 351 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for BOUT moved out of overbought territory on January 14, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BOUT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BOUT broke above its upper Bollinger Band on January 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Alibaba Group Holding Limited (NYSE:BABA), Charles Schwab Corp (The) (NYSE:SCHW), Amgen (NASDAQ:AMGN), Enterprise Products Partners LP (NYSE:EPD), Kinder Morgan (NYSE:KMI), Wheaton Precious Metals Corp (NYSE:WPM), Hess Corp (null:HES), Targa Resources Corp (NYSE:TRGP), EQT Corp (NYSE:EQT), Okta (NASDAQ:OKTA).

Industry description

The investment seeks to track, before fees and expenses, the performance of the IBD® Breakout Stocks Index (the "index"). The fund normally invests at least 80% of its net assets (including borrowings for investment purposes) in the equity securities that comprise the index. The index seeks to provide opportunistic investment exposure to those stocks with the potential to "break out," or experience a period of sustained price growth beyond the stock’s recent “resistance level,” with consideration for various market conditions. The fund is non-diversified.

Market Cap

The average market capitalization across the Innovator IBD® Breakout Opps ETF ETF is 163.68B. The market cap for tickers in the group ranges from 616.5M to 413.72B. BABA holds the highest valuation in this group at 413.72B. The lowest valued company is NPB at 616.5M.

High and low price notable news

The average weekly price growth across all stocks in the Innovator IBD® Breakout Opps ETF ETF was 2%. For the same ETF, the average monthly price growth was 6%, and the average quarterly price growth was 3%. KTOS experienced the highest price growth at 33%, while MMYT experienced the biggest fall at -8%.

Volume

The average weekly volume growth across all stocks in the Innovator IBD® Breakout Opps ETF ETF was 5%. For the same stocks of the ETF, the average monthly volume growth was 6% and the average quarterly volume growth was 5%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 67
P/E Growth Rating: 56
Price Growth Rating: 52
SMR Rating: 53
Profit Risk Rating: 44
Seasonality Score: 22 (-100 ... +100)
View a ticker or compare two or three
BOUT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category MidCapGrowth

Profile
Fundamentals
Details
Category
Mid-Cap Growth
Address
Academy Funds Trust123 South Broad Street, Suite 1630Philadelphia
Phone
(215) 979-3750
Web
www.innovatorfunds.com